Cargando…
Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion
BACKGROUND AND OBJECTIVES: Chimeric antigen receptor (CAR) T-cell therapies have dramatically improved the prognosis of patients with relapsed or refractory hematologic malignancies; however, cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome (ICANS) occur in ∼100 a...
Autores principales: | Huby, Sophie, Gelisse, Philippe, Tudesq, Jean-Jacques, Labauge, Pierre, Duflos, Claire, Cartron, Guillaume, Gallerand, Marc-Antoine, Platon, Laura, Badiou, Stephanie, Lamure, Sylvain, Menjot de Champfleur, Nicolas, Ayrignac, Xavier, Taieb, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119810/ https://www.ncbi.nlm.nih.gov/pubmed/37059470 http://dx.doi.org/10.1212/NXI.0000000000200111 |
Ejemplares similares
-
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
por: Belin, Catherine, et al.
Publicado: (2020) -
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy
por: Lamure, Sylvain, et al.
Publicado: (2021) -
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
por: Ayrignac, Xavier, et al.
Publicado: (2020) -
Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome
por: Taieb, Guillaume, et al.
Publicado: (2021) -
Two neurologic facets of CTLA4-related haploinsufficiency
por: Ayrignac, Xavier, et al.
Publicado: (2020)